Publications
5532 Results
- Journal / Conference
- ASCO 13:279(#897)
- Year
- 1994
- Research Committee(s)
- Head and Neck
- Study Number(s)
- SWOG-9062
Alpha interferon (aIFN) + 5-fluorouracil (5-FU) + cisplatin (CDDP) in advanced squamous cell carcinoma of the head and neck (SCCHN): A Southwest Oncology Group (SWOG) phase II trial.
- Journal / Conference
- Journal of Clinical Oncology 12(9):1868-1875
- Year
- 1994
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8509, SWOG-8708, SWOG-8719, SWOG-8722, SWOG-8955
Effects of continued androgen-deprivation therapy and other prognostic factors on response and survival in phase II chemotherapy trials for hormone-refractory prostate cancer: A Southwest Oncology Group report.
- Journal / Conference
- Investigational New Drugs 12(2):159-161
- Year
- 1994
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8936
Phase II trial of piroxantrone in gastric carcinoma: a Southwest Oncology Group study
- Journal / Conference
- ASCO 13:379(#1287)
- Year
- 1994
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-7204/7205, SWOG-7426/7427, SWOG-7713/14
A clinical analysis of new indolent lymphoma entities in the revised european american lymphoma (REAL) classification.
- Journal / Conference
- ASCO 13:171(#477)
- Year
- 1994
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-7510
With > 4,600 patient-years follow-up, SWOG colorectal adjuvant study suggests that BCG may act as a chemoprevention agent.
- Journal / Conference
- ASCO 13:331(#1096)
- Year
- 1994
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8269
Patterns of failure and second malignancies from SWOG-8269: Concurrent cisplatin (P), etoposide (E), vincristine (V), and once daily radiotherapy (RT) for the treatment of limited small-cell lung cancer (SCLC).
- Journal / Conference
- Lung Cancer 11(Suppl.1):172(#666)
- Year
- 1994
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8269
Long term follow-up (F/U) from SWOG 8269: Concurrent cisplatin (P), etoposide (E), vincristine (V) and daily radiotherapy (TRT) for the treatment of limited small-cell lung cancer (LSCLC): Patterns of failure and second tumors.
- Journal / Conference
- ASCO 13:370(#1251)
- Year
- 1994
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8410, SWOG-8503, SWOG-8508, SWOG-8516 (INT-0067)
African americans treated on SWOG NHL studies: Similar incidence, received dose intensity and outcome to caucasian patients.
- Journal / Conference
- ASCO 13:370(#1250)
- Year
- 1994
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8516 (INT-0067)
Factors affecting reduced survival of the elderly with intermediate and high grade lymphoma: An analysis of SWOG-8516 (INT 0067) - the national high priority lymphoma study - a randomized comparison of CHOP vs m-BACOD vs ProMACE-CytaBOM vs MACOP-B.
- Journal / Conference
- ASCO 13:410(#1401)
- Year
- 1994
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-8624